from Reuters: Technology News https://ift.tt/2YAnwKn
Thursday, August 1, 2019
Chinese drugmaker Chipscreen's STAR Market IPO sees feverish demand
Shenzhen Chipscreen Biosciences, which plans to list on China's red-hot new tech board, said its newly issued shares were almost 3,000-times oversubscribed among retail investors, despite an eye-popping offer pricing of 468-times earnings.
from Reuters: Technology News https://ift.tt/2YAnwKn
from Reuters: Technology News https://ift.tt/2YAnwKn
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
The Devas shareholders are enforcing an International Chamber of Commerce arbitral award of $1.2 billion to Devas, owed by ISRO commercial a...
No comments:
Post a Comment